BAJAJ BROKING

Notification
No new Notification messages
Vishal Mega Mart IPO is Open!
Apply for the Vishal Mega Mart IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
glenmark life science ltd stock

GLENMARK LIFE SCIENCE LTD Share Price

1036.35 -13.50 (-1.28%)
Dec 12 2024 03:30 PM Pharmaceuticals NSE: GLS

GLENMARK LIFE SCIENCE LTD Share Price Update

As of the latest trading session, GLENMARK LIFE SCIENCE LTD share price is currently at 1036.35, which is down by -13.50 from its previous closing. Today, the stock has fluctuated between 1015.80 and 1059.95. Over the past year, GLENMARK LIFE SCIENCE LTD has achieved a return of 63.23 %. In the last month alone, the return has been -3.77 %. Read More...

GLENMARK LIFE SCIENCE LTD Performance

Day Range

Low1015.80 High1059.95
1036.35

52 Week Range

Low 627.15 High 1335.10
1036.35

GLENMARK LIFE SCIENCE LTD Share Price

5265

543322

GLS

img img img img
No Data Available

Open Price

1049.85

Prev. Close

1049.85

Volume (Shares)

80154.00

Total traded value

830.67

Upper Circuit

1259.80

Lower Circuit

839.90

Note: The current prices & values are delayed, Login to your account for live updates.

GLENMARK LIFE SCIENCE LTD Fundamentals


(Standalone)

Market Cap (Cr) 12698.70
PE Ratio (TTM) 29.95
Book Value / Share 207.16
Beta 0.16
ROE 21.07%
EPS (TTM) 34.56
Dividend Yield 2.17%
Net Profit Qtr (Cr) 95.32

GLENMARK LIFE SCIENCE LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 506.88
Operating Expense 387.95
Net Profit 95.32
Net Profit Margin (%) 18.80
Earnings Per Share (EPS) 7.78
EBITDA 142.89
Effective Tax Rate (%) 25.21
Particulars JUN 2024 (Values in Cr)
Revenue 588.62
Operating Expense 443.87
Net Profit 111.48
Net Profit Margin (%) 18.93
Earnings Per Share (EPS) 9.10
EBITDA 164.98
Effective Tax Rate (%) 25.79
Particulars MAR 2024 (Values in Cr)
Revenue 536.60
Operating Expense 410.05
Net Profit 97.94
Net Profit Margin (%) 18.25
Earnings Per Share (EPS) 7.99
EBITDA 144.57
Effective Tax Rate (%) 24.47
Particulars DEC 2023 (Values in Cr)
Revenue 572.80
Operating Expense 413.82
Net Profit 118.77
Net Profit Margin (%) 20.73
Earnings Per Share (EPS) 9.69
EBITDA 174.25
Effective Tax Rate (%) 26.08
Particulars SEP 2023 (Values in Cr)
Revenue 595.36
Operating Expense 441.81
Net Profit 118.74
Net Profit Margin (%) 19.94
Earnings Per Share (EPS) 9.69
EBITDA 172.46
Effective Tax Rate (%) 25.28
Particulars MAR 2024 (Values in Cr)
Revenue 2283.21
Operating Expense 1663.97
Net Profit 470.89
Net Profit Margin (%) 20.62
Earnings Per Share (EPS) 38.43
EBITDA 686.29
Effective Tax Rate (%) 25.40
Particulars MAR 2023 (Values in Cr)
Revenue 2161.22
Operating Expense 1561.57
Net Profit 466.96
Net Profit Margin (%) 21.60
Earnings Per Share (EPS) 38.11
EBITDA 671.25
Effective Tax Rate (%) 25.71
Particulars MAR 2022 (Values in Cr)
Revenue 2123.21
Operating Expense 1572.99
Net Profit 418.72
Net Profit Margin (%) 19.72
Earnings Per Share (EPS) 35.63
EBITDA 630.77
Effective Tax Rate (%) 25.87
Particulars MAR 2021 (Values in Cr)
Revenue 1885.17
Operating Expense 1415.04
Net Profit 351.58
Net Profit Margin (%) 18.64
Earnings Per Share (EPS) 32.61
EBITDA 591.88
Effective Tax Rate (%) 25.34
Particulars MAR 2020 (Values in Cr)
Revenue 1537.31
Operating Expense 1128.24
Net Profit 313.10
Net Profit Margin (%) 20.36
Earnings Per Share (EPS) 29.04
EBITDA 483.96
Effective Tax Rate (%) 25.64
Particulars MAR 2024 (Values in Cr)
Book Value / Share 190.35
ROE % 21.07
ROCE % 27.94
Total Debt to Total Equity 0.01
EBITDA Margin 30.06
Particulars MAR 2023 (Values in Cr)
Book Value / Share 174.51
ROE % 22.28
ROCE % 29.80
Total Debt to Total Equity 0.01
EBITDA Margin 31.06
Particulars MAR 2022 (Values in Cr)
Book Value / Share 167.66
ROE % 29.83
ROCE % 42.20
Total Debt to Total Equity 0.00
EBITDA Margin 29.71
Particulars MAR 2021 (Values in Cr)
Book Value / Share 768.11
ROE % 60.91
ROCE % 96.75
Total Debt to Total Equity 0.00
EBITDA Margin 31.40
Particulars MAR 2020 (Values in Cr)
Book Value / Share 2049.45
ROE % 127.84
ROCE % 185.60
Total Debt to Total Equity 0.00
EBITDA Margin 31.48
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 301.59
Total Assets 2850.41
Total Liabilities 2850.41
Total Equity 2332.32
Share Outstanding 122527172
Price to Book Ratio 4.07
Return on Assets (%) 16.51
Return on Capital (%) 20.19
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 309.39
Total Assets 2702.14
Total Liabilities 2702.14
Total Equity 2138.20
Share Outstanding 122527172
Price to Book Ratio 2.24
Return on Assets (%) 17.28
Return on Capital (%) 21.84
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 512.16
Total Assets 2471.00
Total Liabilities 2471.00
Total Equity 2054.31
Share Outstanding 122527172
Price to Book Ratio 2.74
Return on Assets (%) 16.94
Return on Capital (%) 20.38
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 115.59
Total Assets 1997.07
Total Liabilities 1997.07
Total Equity 752.74
Share Outstanding 9800450
Price to Book Ratio 0.00
Return on Assets (%) 17.60
Return on Capital (%) 46.71
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 9.99
Total Assets 1725.60
Total Liabilities 1725.60
Total Equity 401.69
Share Outstanding 1960090
Price to Book Ratio 0.00
Return on Assets (%) 18.14
Return on Capital (%) 77.94
Particulars MAR 2024 (Values in Cr)
Net Income 631.29
Cash from Operations 576.47
Cash from Investing -116.48
Cash from Financing -279.44
Net change in Cash 17.59
Free Cash Flow 705.44
Particulars MAR 2023 (Values in Cr)
Net Income 628.60
Cash from Operations 459.57
Cash from Investing -146.74
Cash from Financing -387.59
Net change in Cash -228.33
Free Cash Flow 622.36
Particulars MAR 2022 (Values in Cr)
Net Income 564.92
Cash from Operations 735.75
Cash from Investing -122.22
Cash from Financing -78.79
Net change in Cash 396.56
Free Cash Flow 867.92
Particulars MAR 2021 (Values in Cr)
Net Income 470.94
Cash from Operations 496.67
Cash from Investing -68.73
Cash from Financing -213.78
Net change in Cash 105.59
Free Cash Flow 564.67
Particulars MAR 2020 (Values in Cr)
Net Income 421.06
Cash from Operations 287.54
Cash from Investing -50.51
Cash from Financing -136.55
Net change in Cash 7.93
Free Cash Flow 338.70
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.16 37.45 3.55 499.34 37.54 / 77.70
BLISS GVS PHARMA LTD 151.80 19.00 1.58 1598.94 92.25 / 172.40
CIPLA LTD 1454.20 25.44 4.14 117443.01 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 410.00 142.36 4.15 1206.67 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2345.45 49.56 23.75 39733.34 1664.75 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.16 56.66 11.07 499.34 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.55 45.59 7.27 2167.00 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6595.05 128.08 24.26 16487.63 4050.15 / 8139.85
BLISS GVS PHARMA LTD 151.80 19.79 1.56 1598.94 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1053.20
  • 26 Days 1067.20
  • 10 Days 1061.20
  • 50 Days 1071.00
  • 12 Days 1064.60
  • 100 Days 1047.80
  • 20 Days 1069.60
  • 200 Days 892.50
1042.95
PIVOT
First Resistance 1061.90
Second Resistance 1073.95
Third Resistance 1092.90
First Support 1030.90
Second Support 1011.95
Third Support 999.90
RSI 45.26
MACD -2.59
Commodity Channel Index (CCI) -155.39
ADX 12.06
Williams % R -67.92

Over 1 Month

down

-3.77

Over 3 Months

down

-18.57

Over 6 Months

down

21.11

Over 1 Year

down

63.23

Over 3 Years

down

19.39

Over 5 Years

down

0.00

GLENMARK LIFE SCIENCE LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

GLENMARK LIFE SCIENCE LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
0.0
Promoter Holdings
0.0
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Nirma Limited Shareholding of Promoter and Promoter Group 9.1896285E7 75.0
Polar Capital Funds Plc - Healthcare Opportunities Public Shareholding 3423757.0 2.79
Massachusetts Institute Of Technology Public Shareholding 1750000.0 1.43
Quant Mutual Fund - Quant Flexi Cap Fund Public Shareholding 1568647.0 1.28
Glenmark Pharmaceuticals Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Glenn Mario Saldanha Shareholding of Promoter and Promoter Group 0.0 0.0

GLENMARK LIFE SCIENCE LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-10-17 22.5 Interim 2023-10-17 Equity shares 2023-03-24 21.0 Interim 2023-03-24 Equity shares 2022-09-15 10.5 Final 2022-09-17 Equity shares 2021-11-22 10.5 Interim 2021-11-23 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About GLENMARK LIFE SCIENCE LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by GLENMARK LIFE SCIENCE LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Glenmark Life Sciences Ltd?

Answer Field

The share price of Glenmark Life Sciences Ltd for NSE is ₹ 1036.35 and for BSE is ₹ 1038.75.

What is the Market Cap of Glenmark Life Sciences Ltd?

Answer Field

The market cap of Glenmark Life Sciences Ltd for NSE is ₹ 1,26,98.70 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Glenmark Life Sciences Ltd?

Answer Field

The 52 Week High and Low of Glenmark Life Sciences Ltd for NSE is ₹ 1335.10 and ₹ 627.15 and for BSE is ₹ 1335.00 and ₹ 627.25.

How to Buy Glenmark Life Sciences Ltd share?

Answer Field

You can trade in Glenmark Life Sciences Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Glenmark Life Sciences Ltd?

Answer Field

The 1 year returns on the stock has been 63.23%.

What is the Current Share Price of Glenmark Life Sciences Ltd?

Answer Field

Glenmark Life Sciences Ltd share price is for NSE ₹ 1036.35 & for BSE ₹ 1038.75 as on Dec 12 2024 03:30 PM.

What is the Market Cap of Glenmark Life Sciences Ltd Share?

Answer Field

The market cap of Glenmark Life Sciences Ltd for NSE ₹ 1,26,98.70 & for BSE ₹ 0.0 as on Dec 12 2024 03:30 PM.

What is the P/E Ratio of Glenmark Life Sciences Ltd Share?

Answer Field

As on Dec 12 2024 03:30 PM the price-to-earnings (PE) ratio for Glenmark Life Sciences Ltd share is 29.95.

What is the PB ratio of Glenmark Life Sciences Ltd Share?

Answer Field

As on Dec 12 2024 03:30 PM, the price-to-book (PB) ratio for Glenmark Life Sciences Ltd share is 207.16.

How to Buy Glenmark Life Sciences Ltd Share?

Answer Field

You can trade in Glenmark Life Sciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Glenmark Life Sciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Glenmark Life Sciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Glenmark Life Sciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader